These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 26362380)

  • 41. Randomized, double-blind, placebo-controlled phase 2 study of ganaxolone as add-on therapy in adults with uncontrolled partial-onset seizures.
    Sperling MR; Klein P; Tsai J
    Epilepsia; 2017 Apr; 58(4):558-564. PubMed ID: 28230252
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lacosamide tolerability in adult patients with partial-onset seizures: Impact of planned reduction and mechanism of action of concomitant antiepileptic drugs.
    Foldvary-Schaefer N; Fong JS; Morrison S; Wang L; Bena J
    Epilepsy Behav; 2016 Apr; 57(Pt A):155-160. PubMed ID: 26956629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term efficacy and safety of lacosamide monotherapy in the treatment of partial-onset seizures: A multicenter evaluation.
    Giráldez BG; Toledano R; García-Morales I; Gil-Nagel A; López-González FJ; Tortosa D; Ojeda J; Serratosa JM
    Seizure; 2015 Jul; 29():119-22. PubMed ID: 26076854
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lacosamide: A Review in Focal Seizures in Patients with Epilepsy.
    Scott LJ
    Drugs; 2015 Dec; 75(18):2143-54. PubMed ID: 26607484
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety and tolerability of adjunctive lacosamide in a pediatric population with focal seizures - An open-label trial.
    Ferreira JA; Le Pichon JB; Abdelmoity AT; Dilley D; Dedeken P; Daniels T; Byrnes W
    Seizure; 2019 Oct; 71():166-173. PubMed ID: 31374487
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The experience treatment of adjunctive lacosamide for patients with drug-resistance partial epilepsy].
    Kissin MY; Bondarenko II
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(9):23-8. PubMed ID: 24107876
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term safety and efficacy following conversion to eslicarbazepine acetate monotherapy in adults with focal seizures.
    Chung S; Sinha SR; Shah A; Stern JM; Cheng H; Jung J; Grinnell T; Blum D
    Epilepsy Res; 2019 Jul; 153():59-65. PubMed ID: 30999260
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lacosamide in patients with temporal lobe epilepsy: An observational multicentric open-label study.
    Borzì G; Di Gennaro G; Schmitt FC; D'Aniello A; Mumoli L; Zummo L; Daniele O; Russo E; Gambardella A; Labate A
    Epilepsy Behav; 2016 May; 58():111-4. PubMed ID: 27064831
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of lacosamide on the quality of life of patients with epilepsy].
    García-Escrivá A; López-Hernández N; Llorca V; Alfaro A; Asensio-Asensio M; García C; Lezcano-Rodas M; Medrano V; Palao S
    Rev Neurol; 2014 Aug; 59(4):145-52. PubMed ID: 25059264
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term adjunctive lacosamide treatment in patients with partial-onset seizures.
    Rosenow F; Kelemen A; Ben-Menachem E; McShea C; Isojarvi J; Doty P;
    Acta Neurol Scand; 2016 Feb; 133(2):136-144. PubMed ID: 26133811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial.
    Vossler DG; Knake S; O'Brien TJ; Watanabe M; Brock M; Steiniger-Brach B; Williams P; Roebling R;
    J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1067-1075. PubMed ID: 32817358
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Control of seizures in different stages of partial epilepsy: LACO-EXP, a Spanish retrospective study of lacosamide.
    Villanueva V; López FJ; Serratosa JM; González-Giraldez B; Campos D; Molins A; Rodriguez Uranga J; Mauri JA; Salas-Puig J; Toledo M; Sánchez-Alvarez JC; Moreno A; Serrano-Castro PJ; Saiz-Diaz RA; González de la Aleja J; de la Peña P; Asensio M
    Epilepsy Behav; 2013 Nov; 29(2):349-56. PubMed ID: 23999191
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of lacosamide on depression and anxiety symptoms in patients with focal refractory epilepsy: A prospective multicenter study.
    Rocamora R; Ley M; Molins A; Toledo M; Sansa G; Bertol V; Becerra JL; Carreño M; Mauri JÁ
    Epilepsy Behav; 2018 Feb; 79():87-92. PubMed ID: 29253680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and tolerability of treatment with lacosamide: Postmarketing experience from the Middle East region.
    Arabi M; Alsaadi T; Nasreddine W; Al-Hashel J; Dirani M; Beydoun A
    Epilepsy Behav; 2018 Jul; 84():118-121. PubMed ID: 29778846
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lacosamide in pediatric and adult patients: comparison of efficacy and safety.
    Verrotti A; Loiacono G; Pizzolorusso A; Parisi P; Bruni O; Luchetti A; Zamponi N; Cappanera S; Grosso S; Kluger G; Janello C; Franzoni E; Elia M; Spalice A; Coppola G; Striano P; Pavone P; Savasta S; Viri M; Romeo A; Aloisi P; Gobbi G; Ferretti A; Cusmai R; Curatolo P
    Seizure; 2013 Apr; 22(3):210-6. PubMed ID: 23298605
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term tolerability, safety and efficacy of adjunctive perampanel in the open-label, dose-ascending Study 231 and extension Study 233 in Japanese patients with epilepsy.
    Usui N; Akamatsu N; Nakasato N; Ohnishi A; Kaneko S; Hiramatsu H; Saeki K; Miyagishi H; Inoue Y
    Seizure; 2018 Nov; 62():26-32. PubMed ID: 30267941
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized, open-label, multicenter comparative trial of levetiracetam and topiramate as adjunctive treatment for patients with focal epilepsy in Korea.
    Lee SK; Lee SA; Kim DW; Loesch C; Pelgrims B; Osakabe T; Lee B;
    Epilepsy Behav; 2019 Aug; 97():67-74. PubMed ID: 31195326
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LACONORTE study: Efficacy and security of lacosamide as first add-on therapy for focal-onset epilepsy in real-life setting.
    Muñoz-Lopetegi A; López-González FJ; Rodríguez-Osorio X; Pato Pato A; Bellas Lamas P; Abella-Corral J; Castro Vilanova MD; Garea MJ; Gil López JA; Ruiz-Martínez J; Poza JJ
    Epilepsy Res; 2018 Sep; 145():51-54. PubMed ID: 29890341
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lacosamide: in partial-onset seizures.
    Cross SA; Curran MP
    Drugs; 2009; 69(4):449-59. PubMed ID: 19323588
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Russian experience of lacosamide (vimpat) usage in treatment of uncontrolled focal epilepsy].
    Lebedeva AV; Burd SG; Belyaev OV; Vlasov PN; Dorofeeva MY; Ismailov AM; Kissin MY; Kovaleva IY; Koroleva NY; Lipatova LV; Mukhin KY; Solomatin YV; Chervyakov AV; Shikhkerimov RG; Pylaeva OA; Freidkova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(9. Vyp. 2):74-81. PubMed ID: 28005051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.